Archives

Biopharmaceutical industry leaders shape the future of drug development at Veeva R&D and Quality Summit Europe

Veeva Systems

Veeva Systems announced that the executives of Ascendis Pharma A/S, Bayer, Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordisk, Sanofi and Teva will be keynote speakers at the  Veeva R&D and Quality Summit, Europe , taking place June 4-5 in Madrid , Spain. Life sciences professionals from across the industry will come together to discuss how connected technologies in clinical, regulatory, safety and quality are advancing innovations for patients.

As one of the largest gatherings of biopharmaceutical industry leaders in Europe , the Veeva R&D and Quality Summit will bring together more than 1,000 industry professionals who will share their knowledge during more than 100 sessions. Bayer and Jazz Pharmaceuticals will join Rik Van Mol, Senior Vice President of Veeva Development Cloud, and Avril England , General Manager of Veeva Vault, for the keynote to explore the future of new drug development and new therapies.

Also Read: GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications 

The main conferences of the event will be as follows:

  • Ascendis and Bayer will share strategies to reduce costs and accelerate trials through a connected platform.

  • Boehringer Ingelheim  will detail its move to data-centric regulatory information management.

  • Novo Nordisk  will show how it uses data and AI to transform clinical research.

  • Sanofi will explain its innovative approach to advancing quality through operational excellence.

  • Teva will provide insight into its rapid evolution from disparate security systems to a streamlined overall solution.

A panel discussion featuring Terry Pirovolakis, CEO of Elpida Therapeutics, and experts from Veeva will close the event with a discussion on how the industry can best accelerate the development of gene therapies for life-saving rare diseases .

“Connecting clinical, regulatory, safety and quality aspects is critical to advancing the product lifecycle and delivering better patient outcomes,” said Rik Van Mol, senior vice president of Veeva Development Cloud. At the Veeva R&D and Quality Summit, biopharmaceutical industry leaders can connect, exchange ideas and share new strategies to advance the industry together. Veeva is the global leader in cloud software for the life sciences industry. Betting on innovation, product excellence and customer success, Veeva has more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechnology companies.

SOURCE: PRNewswire